Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Sells ProteinChip Systems to Japanese Drug Discovery Proteome Project

NEW YORK, April 19 (GenomeWeb News) - Ciphergen Biosystems announced today that its Japanese subsidiary has been named one of the official technology suppliers of the Japanese Drug Discovery Proteome Factory project.

 

Ciphergen has so far sold to the project three ProteinChip AutoBiomarker Systems and two ProteinChip interfaces for use with tandem mass spec.

 

The five-year Japanese project, which began in 2002, involves 20 Japanese pharma companies and is funded by the Japan Health Science Foundation to the tune of 4.5 billion yen ($41 million). The goal of the project is to gain information on proteins involved in cancer, diabetes, hypertension, asthma, and dementia.

 

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.